Supraphysiologic Testosterone Solutions for Enzalutamide-resistant Prostate Cancer

Eur Urol. 2020 Feb;77(2):156-157. doi: 10.1016/j.eururo.2019.07.037. Epub 2019 Jul 31.

¹ Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA.
² Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA.
³ Genitourinary Malignancies Research Center, Lerner Research Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Urology, Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA; Department of Hematology and Oncology, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: sharifn@ccf.org.

No abstract available

Publication types